These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24857675)

  • 1. Are there guidelines to evaluate claims made for weight-loss products?
    Cunningham E
    J Acad Nutr Diet; 2014 Jun; 114(6):976. PubMed ID: 24857675
    [No Abstract]   [Full Text] [Related]  

  • 2. The Federal Trade Commission's regulation of weight-loss advertising claims.
    Correia E
    Food Drug Law J; 2004; 59(4):585-94. PubMed ID: 15875353
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight loss testimonials: a critique of potential FTC restrictions on diet advertising.
    Nguyen ES
    Food Drug Law J; 2008; 63(2):493-507. PubMed ID: 18561474
    [No Abstract]   [Full Text] [Related]  

  • 4. Expert Panel Report: Guidelines (2013) for the management of overweight and obesity in adults.
    American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013
    Obesity (Silver Spring); 2014 Jul; 22 Suppl 2():S41-410. PubMed ID: 24227637
    [No Abstract]   [Full Text] [Related]  

  • 5. Physicians' personal intake and prescription of weight loss products: are we practicing what we preach?
    La Puma J; Szapary P; Maki KC
    Arch Intern Med; 2004 Apr; 164(7):806-7. PubMed ID: 15078656
    [No Abstract]   [Full Text] [Related]  

  • 6. The battle against deceptive weight loss ads.
    Gross WC
    Crit Rev Food Sci Nutr; 2001 Jan; 41(1):41-2. PubMed ID: 11152045
    [No Abstract]   [Full Text] [Related]  

  • 7. Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting.
    Schwartz SM; Bansal VP; Hale C; Rossi M; Engle JP
    Obesity (Silver Spring); 2008 Mar; 16(3):623-9. PubMed ID: 18239553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 9. Over-the-counter orlistat. A weight loss "Alli" or adversary on the horizon.
    Anderson T
    AWHONN Lifelines; 2006; 10(5):418-21. PubMed ID: 17069574
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dietary supplements and functional food for weight reduction -- expectations and reality].
    Hahn A; Ströhle A; Wolters M
    MMW Fortschr Med; 2003 Oct; 145(42):40-5. PubMed ID: 14655443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the The Obesity Expert Panel, 2013.
    American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013
    Obesity (Silver Spring); 2014 Jul; 22 Suppl 2():S5-39. PubMed ID: 24961825
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural Dietary and Herbal Products in Anti-Obesity Treatment.
    Sun NN; Wu TY; Chau CF
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27727194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are non-prescription medications needed for weight control?
    Bray GA
    Obesity (Silver Spring); 2008 Mar; 16(3):509-14. PubMed ID: 18239604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug management of obesity--efficacy versus safety.
    Astrup A
    N Engl J Med; 2010 Jul; 363(3):288-90. PubMed ID: 20647205
    [No Abstract]   [Full Text] [Related]  

  • 15. Winning at losing: a guide to healthy weight loss. The straight dope on weight-loss drugs.
    Agnew B
    Diabetes Forecast; 2002 Apr; 55(4):51-2, 54-5. PubMed ID: 14964147
    [No Abstract]   [Full Text] [Related]  

  • 16. Dietary supplements: an advertising guide for industry.
    Crit Rev Food Sci Nutr; 2001 Jan; 41(1):71-85. PubMed ID: 11221600
    [No Abstract]   [Full Text] [Related]  

  • 17. The Federal Trade Commission's regulation of advertising claims for dietary supplements.
    Peeler CL; Cohn S
    Food Drug Law J; 1995; 50(3):349-55. PubMed ID: 10343004
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.
    Merlotti C; Morabito A; Pontiroli AE
    Diabetes Obes Metab; 2014 Aug; 16(8):719-27. PubMed ID: 24476122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fat blockers now without a prescription--without diet the reducing pill has little effect (interview by Dr. Judith Neumaier)].
    Hauner H
    MMW Fortschr Med; 2009 May; 151(20):7. PubMed ID: 19728652
    [No Abstract]   [Full Text] [Related]  

  • 20. Multicenter, placebo-controlled trial of lorcaserin for weight management.
    Smith SR; Weissman NJ; Anderson CM; Sanchez M; Chuang E; Stubbe S; Bays H; Shanahan WR;
    N Engl J Med; 2010 Jul; 363(3):245-56. PubMed ID: 20647200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.